WC
IDXX icon

Westerkirk Capital’s Idexx Laboratories IDXX Stock Holding History

Westerkirk Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Hold
1,974
– – 0.1% 115
2026
Q1 		$1.11M Sell
1,974
-138
-7% -$88.5K 0.12% 105
2025
Q4 		$1.43M Buy
2,112
+864
+69% +$588K 0.14% 94
2025
Q3 		$797K Sell
1,248
-113
-8% -$68.6K 0.09% 164
2025
Q2 		$730K Buy
+1,361
New +$651K 0.09% 167

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Westerkirk Capital's IDXX Position: Q2 2026 in Review

Westerkirk Capital held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,974 shares worth $1.04M. The position accounts for 0.1% of the portfolio, ranked #115.

Westerkirk Capital first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.43M in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Westerkirk Capital held 1,974 shares of Idexx Laboratories worth $1.04M as of Q2 2026.
  • Westerkirk Capital left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.1% of Westerkirk Capital's portfolio in Q2 2026, its #115 holding.
  • Westerkirk Capital first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Westerkirk Capital's Idexx Laboratories position peaked at $1.43M in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Westerkirk Capital's 13F filing for Q2 2026, filed 10 Aug 2026.